High-risk infants and young children may benefit from a new class of vaccines, which may save thousands of lives a year in the United States.

The new vaccine, called CNV-19dv, developed by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) is approved for use in the U

Tags: